Biofrontera (BFRI) Drops 0.5% to $0.79 Amid 31% Monthly Decline
Biofrontera (BFRI) dips 0.5% on October 22, but its Phase‑2 sun‑damage pipeline, strategic CRO talks, and FDA focus hint at long‑term upside for niche‑pharma investors.
- BIOFRONTERA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read